Data as of Jul 25
| -0.04 / -0.03%|
The 16 analysts offering 12-month price forecasts for Salix Pharmaceuticals Ltd have a median target of 158.50, with a high estimate of 205.00 and a low estimate of 121.00. The median estimate represents a +19.88% increase from the last price of 132.22.
The current consensus among 18 polled investment analysts is to Buy stock in Salix Pharmaceuticals Ltd. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.